# Caffeine as a Therapy for Parkinson's Disease

> **NCT01738178** · PHASE3 · COMPLETED · sponsor: **McGill University Health Centre/Research Institute of the McGill University Health Centre** · enrollment: 119 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Caffeine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01738178
- **Lead sponsor:** McGill University Health Centre/Research Institute of the McGill University Health Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2016-05-01
- **Final completion:** 2016-12-01
- **Target enrollment:** 119 (ACTUAL)
- **Last updated:** 2017-03-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01738178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01738178, "Caffeine as a Therapy for Parkinson's Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01738178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*